Načítá se...

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial

BACKGROUND: GEN-003 is a candidate therapeutic vaccine for genital herpes simplex virus type 2 (HSV-2). We compared virologic and clinical impact of varying GEN-003 doses. METHODS: Adults with symptomatic HSV-2 received placebo or GEN-003 (30 or 60 µg antigen with 25, 50, or 75 µg adjuvant). Viral s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Van Wagoner, Nicholas, Fife, Kenneth, Leone, Peter A, Bernstein, David I, Warren, Terri, Panther, Lori, Novak, Richard M, Beigi, Richard, Kriesel, John, Tyring, Stephen, Koltun, William, Lucksinger, Gregg, Morris, Amy, Zhang, Bin, McNeil, Lisa K, Tasker, Sybil, Hetherington, Seth, Wald, Anna
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7191615/
https://ncbi.nlm.nih.gov/pubmed/29982727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy415
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!